“Today, a three-judge panel of a US Appeals Court lifted an injunction against the NIH’s revised policy on the funding of stem cell research. The new policy, which would open up research funding to many more human embryonic stem cell lines (hESCs), attracted a lawsuit from researchers who focus on adult stem cells …” (more)
[John Timmer, Ars Technica, 29 April]